Publicaties
Gekozen filters:
Gekozen filters:
Expert opinion on NSCLC small specimen biomarker testing - Part 1: Tissue collection and management KU Leuven
Biomarker testing is crucial for treatment selection in advanced non-small cell lung cancer (NSCLC). However, the quantity of available tissue often presents a key constraint for patients with advanced disease, where minimally invasive tissue biopsy typically returns small samples. In Part 1 of this two-part series, we summarise evidence-based recommendations relating to small sample processing for patients with NSCLC. Generally, tissue biopsy ...
Expert opinion on NSCLC small specimen biomarker testing - Part 2: Analysis, reporting, and quality assessment KU Leuven
The diagnostic work-up for non-small cell lung cancer (NSCLC) requires biomarker testing to guide therapy choices. This article is the second of a two-part series. In Part 1, we summarised evidence-based recommendations for obtaining and processing small specimen samples (i.e. pre-analytical steps) from patients with advanced NSCLC. Here, in Part 2, we summarise evidence-based recommendations relating to analytical steps of biomarker testing ...
Persistent postural perceptual dizziness (PPPD)-a new entity for expert opinion Vrije Universiteit Brussel
Systemic treatment of children and adolescents with atopic dermatitis aged >= 2 years : a Delphi consensus project mapping expert opinion in Northern Europe Universiteit Gent Vrije Universiteit Brussel
ENDO-ERN expert opinion on the differential diagnosis of pubertal delay Universiteit Gent
Assessing ear noise in expert opinion Vrije Universiteit Brussel
Tinnitus as a subjective, individual sensation defies objective proof. In the assessment situation, tinnitus must also be distinguished from physiological or spontaneous hearing sensations.With regard to the new German "Königsteiner Recommendation" and the verdicts of the last few years, against the background of the different concepts of causality in the statutory and private accident insurance, a stringent examination to determine whether ...
Biomarker testing in oncology - Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL KU Leuven
In personalized medicine, predictive biomarker testing is the basis for an appropriate choice of therapy for patients with cancer. An important tool for laboratories to ensure accurate results is participation in external quality assurance (EQA) programs. Several providers offer predictive EQA programs for different cancer types, test methods, and sample types. In 2013, a guideline was published on the requirements for organizing high-quality ...